citric acid, anhydrous has been researched along with Nephrolithiasis in 58 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Nephrolithiasis: Formation of stones in the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To enable citrate therapy without a risk of altering the stone chemical composition and to identify indicators reflecting the degree of metabolic disorders in patients with uric acid nephrolithiasis." | 7.83 | [Modern diagnostic and management aspects of citrate therapy for uric acid nephrolithiasis]. ( Alekseenko, SN; Medvedev, VL; Ryabokon', SS; Tatevosyan, AS; Tonyan, AG, 2016) |
| "Topiramate is an approved drug to treat seizures, but its indications have been extended to other diseases of the nervous system and as an adjuvant to chronic pain." | 7.80 | Calcium nephrolithiasis induced by topiramate. ( Arrabal-Martin, M; Arrabal-Polo, MA; Cano-Garcia, Mdel C; Merino-Salas, S, 2014) |
| "Potassium citrate therapy was associated with statistically significant changes in each of these parameters-citrate increased to 548." | 5.43 | Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis. ( Eisner, BH; Goldfarb, DS; Hernandez, N; Shoag, J; Song, Y, 2016) |
| "The combined consumption of citrate and theobromine may be a promising strategy for the prevention of UA kidney stones." | 5.34 | Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine. ( Benejam, J; Calvó, P; Costa-Bauza, A; Grases, F; Hernandez, Y; Sanchis, P, 2020) |
| " Finally, alternative measures for reducing urinary risk factors, such as probiotics, show promise in reducing urinary oxalate and may be effective in the treatment of primary and enteric hyperoxaluria or even idiopathic calcium oxalate nephrolithiasis." | 4.85 | Update on the medical management of stone disease. ( Pearle, MS; Tracy, CR, 2009) |
| "Low fluid intake, low urinary citrate excretion, and high oxidative stress are main causative factors of calcium oxalate (CaOx) nephrolithiasis." | 4.12 | HydroZitLa inhibits calcium oxalate stone formation in nephrolithic rats and promotes longevity in nematode Caenorhabditis elegans. ( Boonla, C; Chotechuang, N; Chuenwisad, K; Jindatip, D; Leelahavanichkul, A; Lordumrongkiat, N; Ma-On, C; Prasanth, MI; Tencomnao, T, 2022) |
| "Oxalate and citrate in 24 h urine and serum are considered to be associated with the incidence and recurrence risk of calcium oxalate kidney stones." | 4.12 | Simultaneous determination of oxalate and citrate in urine and serum of calcium oxalate kidney stone rats by IP-RP LC-MS/MS. ( Chen, M; Gong, L; Li, W; Liu, B; Liu, Z; Zheng, J, 2022) |
| "This study revealed a metabolic tendency to hypercalciuria in calcium oxalate stone patients, predominantly in those with recurrent calcium oxalate urolithiasis." | 3.83 | Metabolic assessment of recurrent and first renal calcium oxalate stone formers. ( Çakıroğlu, B; Eyyupoğlu, E; Hazar, AI; Nuhoğlu, B; Uyanik, BS, 2016) |
| " Metabolic abnormalities were significantly more present in patients with mixed infected stones (struvite+/-apatite and calcium oxalate) than in patients with pure infected stones (struvite+/-carbonate apatite): hypercalciuria in 40%, hyperoxaluria in 34% and hyperuricosuria in 28% (p < 0." | 3.83 | Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary? ( Cicerello, E; Cova, GD; Maccatrozzo, L; Mangano, M; Merlo, F, 2016) |
| "To enable citrate therapy without a risk of altering the stone chemical composition and to identify indicators reflecting the degree of metabolic disorders in patients with uric acid nephrolithiasis." | 3.83 | [Modern diagnostic and management aspects of citrate therapy for uric acid nephrolithiasis]. ( Alekseenko, SN; Medvedev, VL; Ryabokon', SS; Tatevosyan, AS; Tonyan, AG, 2016) |
| "We used computer modeling to investigate the influence of physicochemical stone risk factors on urinary supersaturation (SS) of calcium oxalate (CaOx) in patients with severe hyperoxaluria, relative hypocalciuria, hypocitraturia, and CaOx nephrolithiasis after extensive small bowel resection, usually performed for Crohn's disease." | 3.80 | Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols. ( Allie-Hamdulay, S; Jackson, GE; Rodgers, AL; Sutton, RA, 2014) |
| "Topiramate is an approved drug to treat seizures, but its indications have been extended to other diseases of the nervous system and as an adjuvant to chronic pain." | 3.80 | Calcium nephrolithiasis induced by topiramate. ( Arrabal-Martin, M; Arrabal-Polo, MA; Cano-Garcia, Mdel C; Merino-Salas, S, 2014) |
| "ACP recommends pharmacologic monotherapy with a thiazide diuretic, citrate, or allopurinol to prevent recurrent nephrolithiasis in patients with active disease in which increased fluid intake fails to reduce the formation of stones." | 3.80 | Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. ( Dallas, P; Denberg, TD; Forciea, MA; Qaseem, A; Starkey, M, 2014) |
| "Metabolic syndrome trait clustering is associated with greater severity of kidney stone disease; increased urinary calcium, uric acid, and oxalate excretion; and decreased urinary citrate excretion." | 3.79 | Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. ( Hara, I; Iguchi, M; Inagaki, T; Kohjimoto, Y; Matsumura, N; Sasaki, Y, 2013) |
| "Its importance in nephrolithiasis stems from its ability to form soluble complexes with calcium and to interfere with crystal formation, thus exerting a dual inhibition, thermodynamic and kinetic." | 2.55 | [Use of citrate in patients with nephrolithiasis]. ( Marangella, M, 2017) |
| "Treatment with potassium citrate is effective in patients with primary or secondary hypocitraturia and acidification disorders, which cause unduly acidic urine pH persistently." | 2.49 | [Citrate and renal stones]. ( del Valle, EE; Negri, AL; Spivacow, FR, 2013) |
| "She was diagnosed with Systemic Lupus erythematosus (SLE) and Sjogren's syndrome and was started on mycophenalate mofetil." | 1.91 | Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases. ( Clark, BA; Manzi, S; Osman, O; Wasko, MC, 2023) |
| "Thirty infants with nephrolithiasis and 30 healthy infants exclusively breastfed for the first 6 months of life were included in this prospective cohort case-control study." | 1.62 | Nephrolithiasis during the first 6 months of life in exclusively breastfed infants. ( Altıntaş, F; Koçyiğit, A; Yılmaz, N; Yüksel, S, 2021) |
| "Potassium citrate therapy was associated with statistically significant changes in each of these parameters-citrate increased to 548." | 1.43 | Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis. ( Eisner, BH; Goldfarb, DS; Hernandez, N; Shoag, J; Song, Y, 2016) |
| "Nephrolithiasis is a frequent problem that can cause serious morbidity." | 1.40 | Hypocitraturia: a common but not well-known cause of nephrolithiasis. ( Bos, S; Nap, RR; van der Kleij, FG; Wouters, RS, 2014) |
| "Nephrolithiasis was confirmed radiographically in 39/56 patients (69." | 1.38 | Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. ( Gettman, MT; Krambeck, AE; McPhail, EF; Patterson, DE; Rangel, LJ, 2012) |
| "The prevalence of hyperoxaluria (47% vs 10." | 1.36 | Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. ( Guth, ES; Livingston, EH; Maalouf, NM; Sakhaee, K; Tondapu, P, 2010) |
| "Treatment with potassium citrate corrects the metabolic abnormalities seen in patients with Hcit and UAUpH." | 1.36 | Long-term treatment of renal lithiasis with potassium citrate. ( Del Valle, EE; Negri, AL; Polonsky, A; Spivacow, FR, 2010) |
| "Hypercalciuria was found in 25 (40%) patients." | 1.35 | Risk factors for nephrolithiasis in children. ( Acar, B; Dallar, Y; Emeksiz, S; Inci Arikan, F, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.72) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (10.34) | 29.6817 |
| 2010's | 41 (70.69) | 24.3611 |
| 2020's | 10 (17.24) | 2.80 |
| Authors | Studies |
|---|---|
| Lordumrongkiat, N | 1 |
| Chotechuang, N | 1 |
| Prasanth, MI | 1 |
| Jindatip, D | 1 |
| Ma-On, C | 1 |
| Chuenwisad, K | 1 |
| Leelahavanichkul, A | 1 |
| Tencomnao, T | 1 |
| Boonla, C | 2 |
| Li, W | 1 |
| Zheng, J | 1 |
| Chen, M | 1 |
| Liu, B | 1 |
| Liu, Z | 1 |
| Gong, L | 1 |
| Osman, O | 1 |
| Manzi, S | 1 |
| Wasko, MC | 1 |
| Clark, BA | 1 |
| Assimos, DG | 2 |
| Boydston, K | 1 |
| Terry, R | 1 |
| Winship, B | 1 |
| Davis, L | 1 |
| Yttri, S | 1 |
| Carlos, E | 1 |
| Scales, C | 1 |
| Lipkin, M | 1 |
| Preminger, GM | 3 |
| Hernandez, Y | 1 |
| Costa-Bauza, A | 2 |
| Calvó, P | 1 |
| Benejam, J | 1 |
| Sanchis, P | 1 |
| Grases, F | 3 |
| Yılmaz, N | 1 |
| Yüksel, S | 1 |
| Altıntaş, F | 1 |
| Koçyiğit, A | 1 |
| Patel, PM | 1 |
| Kandabarow, AM | 1 |
| Aiwerioghene, E | 1 |
| Blanco-Martinez, E | 1 |
| Hart, S | 1 |
| Leehey, DJ | 1 |
| Farooq, A | 1 |
| Baldea, KG | 1 |
| Turk, TMT | 1 |
| Abu-Ghanem, Y | 2 |
| Kleinmann, N | 2 |
| Erlich, T | 1 |
| Winkler, HZ | 2 |
| Zilberman, DE | 2 |
| Lan, Y | 1 |
| Zhu, W | 1 |
| Duan, X | 1 |
| Deng, T | 1 |
| Li, S | 1 |
| Liu, Y | 1 |
| Yang, Z | 1 |
| Wen, Y | 1 |
| Luo, L | 1 |
| Zhao, S | 1 |
| Wang, J | 1 |
| Zhao, Z | 1 |
| Wu, W | 1 |
| Zeng, G | 1 |
| Wang, Z | 1 |
| Zhang, Y | 1 |
| Wei, W | 1 |
| Trojan, BP | 1 |
| Trojan, SJ | 1 |
| Navetta, A | 1 |
| Staches, B | 1 |
| Sutton, B | 1 |
| Filleur, S | 1 |
| Nelius, T | 1 |
| Marangella, M | 1 |
| Otto, BJ | 1 |
| Bozorgmehri, S | 1 |
| Kuo, J | 1 |
| Canales, M | 1 |
| Bird, VG | 1 |
| Canales, B | 1 |
| Khedr, M | 1 |
| Milan, AM | 1 |
| Davison, AS | 1 |
| Shvero, A | 1 |
| Li, K | 1 |
| Luo, Y | 1 |
| Mo, Y | 1 |
| Shen, J | 1 |
| Liu, X | 1 |
| Li, H | 1 |
| Udomsilp, P | 1 |
| Saepoo, S | 1 |
| Ittiwut, R | 1 |
| Shotelersuk, V | 1 |
| Dissayabutra, T | 1 |
| Tosukhowong, P | 1 |
| Patel, RM | 1 |
| Jiang, P | 1 |
| Asplin, J | 1 |
| Granja, I | 1 |
| Capretz, T | 1 |
| Osann, K | 1 |
| Okhunov, Z | 1 |
| Landman, J | 1 |
| Clayman, RV | 1 |
| Kohjimoto, Y | 1 |
| Sasaki, Y | 1 |
| Iguchi, M | 1 |
| Matsumura, N | 1 |
| Inagaki, T | 1 |
| Hara, I | 1 |
| Reid, DG | 1 |
| Duer, MJ | 1 |
| Jackson, GE | 2 |
| Murray, RC | 1 |
| Rodgers, AL | 2 |
| Shanahan, CM | 1 |
| del Valle, EE | 2 |
| Spivacow, FR | 2 |
| Negri, AL | 2 |
| Schwaderer, AL | 1 |
| Kusumi, K | 1 |
| Ayoob, RM | 1 |
| Suvagandha, D | 1 |
| Nishijo, M | 1 |
| Swaddiwudhipong, W | 1 |
| Honda, R | 1 |
| Ohse, M | 1 |
| Kuhara, T | 1 |
| Nakagawa, H | 1 |
| Ruangyuttikarn, W | 1 |
| Alex, M | 1 |
| Sauganth Paul, MV | 1 |
| Abhilash, M | 1 |
| Mathews, VV | 1 |
| Anilkumar, TV | 1 |
| Nair, RH | 1 |
| Allie-Hamdulay, S | 1 |
| Sutton, RA | 1 |
| Saez-Torres, C | 2 |
| Rodriguez, A | 1 |
| Rodrigo, D | 2 |
| Frontera, G | 2 |
| Berga, F | 1 |
| Fakier, S | 1 |
| Merino-Salas, S | 1 |
| Arrabal-Polo, MA | 3 |
| Cano-Garcia, Mdel C | 1 |
| Arrabal-Martin, M | 3 |
| Qaseem, A | 1 |
| Dallas, P | 1 |
| Forciea, MA | 1 |
| Starkey, M | 1 |
| Denberg, TD | 1 |
| Bos, S | 1 |
| Nap, RR | 1 |
| Wouters, RS | 1 |
| van der Kleij, FG | 1 |
| Song, Y | 1 |
| Hernandez, N | 1 |
| Shoag, J | 1 |
| Goldfarb, DS | 2 |
| Eisner, BH | 5 |
| Girón-Prieto, MS | 1 |
| Arias-Santiago, S | 2 |
| Del Carmen Cano-García, M | 1 |
| Poyatos-Andújar, A | 2 |
| de Haro-Muñoz, T | 1 |
| Abad-Menor, F | 1 |
| Quesada-Charneco, M | 1 |
| Çakıroğlu, B | 1 |
| Eyyupoğlu, E | 1 |
| Hazar, AI | 1 |
| Uyanik, BS | 1 |
| Nuhoğlu, B | 1 |
| Cicerello, E | 1 |
| Mangano, M | 1 |
| Cova, GD | 1 |
| Merlo, F | 1 |
| Maccatrozzo, L | 1 |
| Al'-Shukri, SK | 1 |
| Slesarevskaya, MN | 1 |
| Kuz'min, IV | 1 |
| Alekseenko, SN | 1 |
| Tatevosyan, AS | 1 |
| Medvedev, VL | 1 |
| Tonyan, AG | 1 |
| Ryabokon', SS | 1 |
| Haleblian, GE | 2 |
| Leitao, VA | 1 |
| Pierre, SA | 1 |
| Robinson, MR | 1 |
| Albala, DM | 1 |
| Ribeiro, AA | 1 |
| Acar, B | 1 |
| Inci Arikan, F | 1 |
| Emeksiz, S | 1 |
| Dallar, Y | 1 |
| Tracy, CR | 1 |
| Pearle, MS | 1 |
| Taylor, EN | 1 |
| Curhan, GC | 1 |
| Eisenberg, ML | 1 |
| Stoller, ML | 2 |
| Maalouf, NM | 1 |
| Tondapu, P | 1 |
| Guth, ES | 1 |
| Livingston, EH | 1 |
| Sakhaee, K | 1 |
| Polonsky, A | 1 |
| Venn-Watson, SK | 1 |
| Townsend, FI | 1 |
| Daniels, RL | 1 |
| Sweeney, JC | 1 |
| McBain, JW | 1 |
| Klatsky, LJ | 1 |
| Hicks, CL | 1 |
| Staggs, LA | 1 |
| Rowles, TK | 1 |
| Schwacke, LH | 1 |
| Wells, RS | 1 |
| Smith, CR | 1 |
| Kurtz, MP | 1 |
| Baumann, JM | 1 |
| Affolter, B | 1 |
| Casella, R | 1 |
| Sumorok, NT | 1 |
| Asplin, JR | 1 |
| McPhail, EF | 1 |
| Gettman, MT | 1 |
| Patterson, DE | 1 |
| Rangel, LJ | 1 |
| Krambeck, AE | 1 |
| Guo, WP | 1 |
| Fung, YS | 1 |
| McMahon, GM | 1 |
| Seifter, JL | 1 |
| Garrido-Gomez, J | 1 |
| Zuluaga-Gomez, A | 1 |
| Smith, D | 1 |
| Laing, C | 1 |
| Sheth, S | 1 |
| Dretler, SP | 1 |
| Herrick, B | 1 |
| Pais, VM | 1 |
| García-Raja, AM | 1 |
| Gómez, C | 1 |
| MCINTOSH, HW | 1 |
| SERAGLIA, M | 1 |
| Kang, DE | 1 |
| Sur, RL | 1 |
| Fitzsimons, NJ | 1 |
| Borawski, KM | 1 |
| Yilmaz, E | 1 |
| Batislam, E | 1 |
| Basar, M | 1 |
| Tuglu, D | 1 |
| Erguder, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL)[NCT04073719] | 50 participants (Anticipated) | Interventional | 2019-09-01 | Not yet recruiting | |||
| A Pilot Study to Assess the Effects of Regulating Urine pH Levels for Alleviating Chronic Joint Pain[NCT01421160] | Phase 1 | 0 participants (Actual) | Interventional | 2011-07-31 | Withdrawn (stopped due to PI left the institution prior to any data being collected) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for citric acid, anhydrous and Nephrolithiasis
| Article | Year |
|---|---|
Effect of dietary treatment and fluid intake on the prevention of recurrent calcium stones and changes in urine composition: A meta-analysis and systematic review.
Topics: Adult; Calcium, Dietary; Citric Acid; Diet, Protein-Restricted; Diet, Sodium-Restricted; Dietary Fib | 2021 |
[Use of citrate in patients with nephrolithiasis].
Topics: Citric Acid; Crystallization; Humans; Kidney Calculi; Nephrolithiasis | 2017 |
[Citrate and renal stones].
Topics: Adult; Calcium Oxalate; Child; Citric Acid; Diuretics; Humans; Hydrogen-Ion Concentration; Kidney; N | 2013 |
Pediatric nephrolithiasis and the link to bone metabolism.
Topics: Absorptiometry, Photon; Bone and Bones; Bone Density; Bone Density Conservation Agents; Child; Child | 2014 |
Update on the medical management of stone disease.
Topics: Animals; Calcium Oxalate; Citric Acid; Diet; Fructose; Humans; Nephrolithiasis; Probiotics; Secondar | 2009 |
Dietary therapy for patients with hypocitraturic nephrolithiasis.
Topics: Animals; Beverages; Calcium Oxalate; Citric Acid; Diet Therapy; Humans; Nephrolithiasis | 2011 |
Challenges in the diagnostic and therapeutic approach to nephrolithiasis.
Topics: Citric Acid; Diet; Humans; Hydrogen-Ion Concentration; Hypercalciuria; Hyperoxaluria; Nephrolithiasi | 2012 |
1 trial available for citric acid, anhydrous and Nephrolithiasis
| Article | Year |
|---|---|
Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine.
Topics: Aged; Citric Acid; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Combinations; | 2020 |
50 other studies available for citric acid, anhydrous and Nephrolithiasis
| Article | Year |
|---|---|
HydroZitLa inhibits calcium oxalate stone formation in nephrolithic rats and promotes longevity in nematode Caenorhabditis elegans.
Topics: Animals; Antioxidants; Caenorhabditis elegans; Calcium Oxalate; Citric Acid; Ethylene Glycol; Female | 2022 |
Simultaneous determination of oxalate and citrate in urine and serum of calcium oxalate kidney stone rats by IP-RP LC-MS/MS.
Topics: Amines; Animals; Calcium Oxalate; Chromatography, Liquid; Citric Acid; Ions; Kidney Calculi; Nephrol | 2022 |
Case report: disease mechanisms and medical management of calcium nephrolithiasis in rheumatologic diseases.
Topics: Adult; Arthritis, Rheumatoid; Calcium; Citric Acid; Female; Humans; Kidney Calculi; Lupus Erythemato | 2023 |
Re: The Impact of Potassium Citrate Therapy in the Natural Course of Medullary Sponge Kidney with Associated Nephrolithiasis.
Topics: Citrates; Citric Acid; Humans; Kidney Calculi; Medullary Sponge Kidney; Nephrolithiasis; Potassium C | 2019 |
The Impact of Alternative Alkalinizing Agents on 24-Hour Urine Parameters.
Topics: Aged; Antacids; Citric Acid; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nephroli | 2020 |
Nephrolithiasis during the first 6 months of life in exclusively breastfed infants.
Topics: Breast Feeding; Calcium; Case-Control Studies; Citric Acid; Creatinine; Female; Humans; Infant; Kidn | 2021 |
Proton-pump inhibitors associated with decreased urinary citrate excretion.
Topics: Adult; Aged; Citric Acid; Female; Humans; Male; Middle Aged; Nephrolithiasis; Proton Pump Inhibitors | 2021 |
The Impact of Dietary Modifications and Medical Management on 24-Hour Urinary Metabolic Profiles and the Status of Renal Stone Disease in Recurrent Stone Formers.
Topics: Aftercare; Calcium; Citric Acid; Diet Therapy; Female; Humans; Israel; Kidney Calculi; Male; Medicat | 2021 |
Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate.
Topics: Animals; Antiporters; Calcium Oxalate; Case-Control Studies; Cell Line; Citric Acid; Crystallization | 2021 |
Novel porcine model for calcium oxalate stone formation.
Topics: Ammonium Chloride; Animals; Blood Urea Nitrogen; Calcium Oxalate; Citric Acid; Creatinine; Disease M | 2017 |
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Topics: Adolescent; Adult; Age Factors; Aged; Body Mass Index; Calcium; Calcium Oxalate; Calcium Phosphates; | 2017 |
Liquid chromatography tandem mass spectrometry: challenges in introducing published methods into the clinical laboratory.
Topics: Chromatography, Liquid; Citrates; Citric Acid; Humans; Nephrolithiasis; Oxalates; Tandem Mass Spectr | 2018 |
24-h urine metabolic profile: is it necessary in all kidney stone formers?
Topics: Adult; Aged; Body Mass Index; Calcium; Citric Acid; Comorbidity; Diabetes Mellitus; Female; Humans; | 2018 |
Association between vitamin D receptor gene polymorphisms and idiopathic hypocitraturia in a Chinese Bai population.
Topics: Adult; Asian People; Case-Control Studies; China; Citric Acid; Female; Genetic Association Studies; | 2019 |
rs11567842 SNP in SLC13A2 gene associates with hypocitraturia in Thai patients with nephrolithiasis.
Topics: Adult; Asian People; Calcium Oxalate; Citric Acid; Dicarboxylic Acid Transporters; Female; Genotype; | 2018 |
Coconut Water: An Unexpected Source of Urinary Citrate.
Topics: Adult; Alkalies; Beverages; Chlorides; Citric Acid; Cocos; Female; Humans; Hydrogen-Ion Concentratio | 2018 |
Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Topics: Adult; Aged; Body Mass Index; Citrates; Citric Acid; Cross-Sectional Studies; Female; Humans; Hyperc | 2013 |
Citrate occurs widely in healthy and pathological apatitic biomineral: mineralized articular cartilage, and intimal atherosclerotic plaque and apatitic kidney stones.
Topics: Animals; Apatites; Calcification, Physiologic; Calcinosis; Calcium Phosphates; Cartilage, Articular; | 2013 |
A biomarker found in cadmium exposed residents of Thailand by metabolome analysis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cadmium; Cadmium Poisoning; Calcium; Citric Acid; Enviro | 2014 |
Astaxanthin modulates osteopontin and transforming growth factor β1 expression levels in a rat model of nephrolithiasis: a comparison with citrate administration.
Topics: Animals; Chelating Agents; Citric Acid; Disease Models, Animal; Down-Regulation; Immunohistochemistr | 2014 |
Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Topics: Calcium Oxalate; Calcium, Dietary; Chelating Agents; Citric Acid; Clinical Protocols; Computer Simul | 2014 |
Urinary phytate (Myo-inositol hexaphosphate) in healthy school children and risk of nephrolithiasis.
Topics: Child; Child, Preschool; Citric Acid; Cohort Studies; Diet; Feeding Behavior; Female; Humans; Male; | 2014 |
Calcium nephrolithiasis induced by topiramate.
Topics: Adult; Aged; Analgesics; Calcium Oxalate; Calcium Phosphates; Chronic Pain; Citric Acid; Female; Fru | 2014 |
Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians.
Topics: Adult; Allopurinol; Calcium Chelating Agents; Citric Acid; Fluid Therapy; Gout Suppressants; Humans; | 2014 |
Hypocitraturia: a common but not well-known cause of nephrolithiasis.
Topics: Adult; Citric Acid; Diuretics; Female; Humans; Nephrolithiasis; Potassium Citrate | 2014 |
Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
Topics: Adult; Aged; Antacids; Calcium; Citric Acid; Female; Humans; Hydrogen-Ion Concentration; Male; Middl | 2016 |
Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Remodeling; Calc | 2016 |
Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
Topics: Adult; Calcium; Calcium Oxalate; Citric Acid; Female; Follow-Up Studies; Humans; Hypercalciuria; Kid | 2016 |
Re: Potassium Citrate Decreases Urine Calcium Excretion in Patients with Hypocitraturic Calcium Oxalate Nephrolithiasis.
Topics: Calcium; Calcium Oxalate; Citrates; Citric Acid; Humans; Kidney Calculi; Nephrolithiasis; Potassium | 2016 |
Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Topics: Adolescent; Adult; Aged; Apatites; Calcium Oxalate; Citric Acid; Female; Follow-Up Studies; Humans; | 2016 |
[Litholytic therapy for urate nephrolithiasis].
Topics: Adult; Aged; Citric Acid; Female; Humans; Lithotripsy; Male; Middle Aged; Nephrolithiasis; Uric Acid | 2016 |
[Modern diagnostic and management aspects of citrate therapy for uric acid nephrolithiasis].
Topics: Citric Acid; Female; Humans; Male; Nephrolithiasis; Uric Acid | 2016 |
Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis.
Topics: Beverages; Citric Acid; Citrus; Fruit; Humans; Magnetic Resonance Spectroscopy; Nephrolithiasis; Nut | 2008 |
Risk factors for nephrolithiasis in children.
Topics: Adolescent; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Follow-Up Studies; Hematuria; | 2008 |
Demographic, dietary, and urinary factors and 24-h urinary calcium excretion.
Topics: Adult; Age Distribution; Aged; Calcium, Dietary; Citric Acid; Demography; Female; Follow-Up Studies; | 2009 |
Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
Topics: Academic Medical Centers; Adult; Age Factors; Aged; Body Mass Index; Calcium Oxalate; Citric Acid; C | 2010 |
Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
Topics: Citric Acid; Cross-Sectional Studies; Female; Gastric Bypass; Humans; Hyperoxaluria; Kidney Diseases | 2010 |
Long-term treatment of renal lithiasis with potassium citrate.
Topics: Adult; Citric Acid; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Hydrogen-Ion Concent | 2010 |
Hypocitraturia in common bottlenose dolphins (Tursiops truncatus): assessing a potential risk factor for urate nephrolithiasis.
Topics: Animals; Bottle-Nosed Dolphin; Citric Acid; Creatinine; Humans; Hydrogen-Ion Concentration; Nephroli | 2010 |
Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium Oxalate; Case-Control Studies; Citric Acid; Crys | 2011 |
Effect of diet orange soda on urinary lithogenicity.
Topics: Adult; Carbonated Beverages; Citric Acid; Citrus sinensis; Cross-Over Studies; Female; Humans; Hydro | 2012 |
Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citric Acid; Diuresis; Female; Humans; Hypercalciuria; H | 2012 |
Microfluidic chip-capillary electrophoresis with dynamic multi-segment standard addition for rapidly identifying nephrolithiasis markers in urine.
Topics: Biomarkers; Citric Acid; Electrophoresis, Microchip; Equipment Design; Humans; Limit of Detection; N | 2011 |
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.
Topics: Adult; Biomarkers; Bone Density; Calcium; Calculi; Citric Acid; Confidence Intervals; Creatinine; Cr | 2013 |
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.
Topics: Calcium; Calculi; Citric Acid; Decalcification, Pathologic; Female; Humans; Male; Nephrolithiasis | 2013 |
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
Topics: Adult; Aged; Citric Acid; Female; Humans; Hypercalciuria; Hyperoxaluria; Linear Models; Male; Middle | 2012 |
Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis.
Topics: Biomarkers; Calcium; Chi-Square Distribution; Child; Child, Preschool; Citric Acid; Female; Genetic | 2013 |
URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
Topics: Calcium; Calcium, Dietary; Citrates; Citric Acid; Diet; Humans; Kidney Calculi; Male; Nephrolithiasi | 1963 |
Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis.
Topics: Adult; Aged; Beverages; Citric Acid; Citrus; Female; Humans; Male; Metabolic Diseases; Middle Aged; | 2007 |
Citrate levels in fresh tomato juice: a possible dietary alternative to traditional citrate supplementation in stone-forming patients.
Topics: Beverages; Citric Acid; Citrus; Diet; Dietary Supplements; Humans; Nephrolithiasis; Solanum lycopers | 2008 |